vision loss with tirzepatide issues Semaglutide linked to higher risk of vision problems, FDA data analysis shows Vision loss risks in patients

Mg Units (40 mg vial + 2.0 mL BAC water = 20 mg/mL) Weekly dose 2.5 mg Volume 0.125 mL U-100 syringe units 12.5 units Weekly dose 5 mg Volume 0.25 mL U-100 syringe units 25 units Weekly dose 7.5 mg Volume 0.375 mL U-100 syringe units 37.5 units Weekly dose 10 mg Volume 0.50 mL U-100 syringe units 50 units Weekly dose 12.5 mg Volume 0.625 mL U-100 syringe units 62.5 units Weekly dose 15 mg Volume 0.75 mL U-100 syringe units 75 units On a 0.5 mL / 50-unit syringe, 12.5 mg and 15 mg need a larger syringe

Underlying health conditions such as cardiovascular disease, diabetes complications, depression, or other chronic illnesses continue to affect sexual function regardless of tirzepatide treatment

Very easy and quick

Diarrhea occurs in 18% to 23% of participants

Steps to Starting Your Program Step 1: Take the Assessment

Fatigue and energy changes Some people experience fatigue in the early weeks, particularly during dose escalation